Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.312 EUR | -4.29% | -8.24% | -22.19% |
Mar. 11 | Biofrontera Files Prospectus for Potential Secondary Stock Offerings | MT |
Mar. 05 | Medicus Pharma Names COO | MT |
Business Summary
Number of employees: 92
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical and Medical Products
100.0
%
| 29 | 100.0 % | 26 | 100.0 % | -10.59% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
66.6
%
| 20 | 70.3 % | 17 | 66.6 % | -15.19% |
Germany
18.5
%
| 5 | 18.3 % | 5 | 18.5 % | -9.50% |
Europe
13.6
%
| 3 | 11.4 % | 3 | 13.6 % | +6.94% |
Other Regions
1.3
%
| - | - | 0 | 1.3 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 55 | 22-09-11 | |
Anke zur Muehlen
IRO | Public Communications Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 63 | 21-12-13 | |
Director/Board Member | - | 21-12-13 | |
Heikki Lanckriet
BRD | Director/Board Member | 47 | 21-12-13 |
Helge Lubenow
BRD | Director/Board Member | 56 | 21-12-13 |
Director/Board Member | 65 | 22-08-22 | |
Jörgen Thielmann
BRD | Director/Board Member | - | 21-12-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 63,807,058 | 20,671,796 ( 32.40 %) | 0 | 32.40 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
BIOFRONTERA INC. 7.86% | 400,000 | 7.86% | 616,000 $ |
Company contact information
Sector
Sales per region
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.19% | 22.18M | |
+24.60% | 672B | |
+24.08% | 550B | |
-5.63% | 351B | |
+15.37% | 317B | |
+7.38% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.69% | 144B | |
-6.63% | 141B |
- Stock Market
- Equities
- B8F Stock
- Company Biofrontera AG